Atlas Trials

Ocrelizumab Effects on the Metabolome in MS

Clinical trial NCT03873389 · COMPLETED

Trial details

NCT number
NCT03873389
Sponsor
Johns Hopkins University
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Sclerosis
Start date
2019-06-12
Primary completion
2023-06-22
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.